NeuroSense Therapeutics is progressing towards fast-track approval for its ALS drug in Canada, potentially leading to a major partnership. BiomX Inc. has received significant funding for its bacteriophage therapies, showing promising results in clinical trials. ABVC BioPharma is developing a botanical antidepressant with innovative potential for treating Major Depressive Disorder. Gilead Sciences is supporting a program providing integrative care for metastatic breast cancer patients. Additionally, San Francisco Dental Implant Center emphasizes the importance of single-tooth dental implants, while Ourian Plastic Surgery achieves success in liposuction services with positive patient reviews.
